Breaking News Instant updates and real-time market news.

2016-10-11 08:34:10

HON

Honeywell

$106.80

-0.14 (-0.13%)

08:34

10/11/16

10/11

08:34

10/11/16

08:34

Honeywell weakness creates buying opportunity, says Argus

Argus analyst John Eade notes that Honeywell has dropped 10% after the company lowered its 2016 EPS guidance. Eade says that the decline in the guidance was "modest," and he thinks that the company continues to have a number of positive catalysts, including "diverse product lines," its "strong presence" in the aerospace and commercial markets and its exposure to growing markets in China. Eade expects the company "to generate low double-digit earnings growth over the next five years." He keeps a $130 price target and Buy rating on the stock.

12

Oct

21

Oct

HONHoneywell

$106.80

-0.14 (-0.13%)

10/07/16

JPMS

10/07/16NO CHANGEJPMSOverweight

Honeywell selloff on guidance a buying opportunity, says JPMorgan

JPMorgan analyst C. Stephen Tusa recommends using the selloff in shares of Honeywell following the company's Q3 guidance cut as a buying opportunity. The analyst puts himself in the "not that bad in the grand scheme" camp and notes Honeywell has $25B in balance sheet capacity. Tusa has an Overweight rating on the shares.

10/10/16

GSCO

10/10/16DOWNGRADETarget $122GSCOBuy

Honeywell downgraded to Buy from Conviction Buy at Goldman

Goldman analyst Joe Ritchie removed Honeywell form the Conviction Buy List following the Q3 preannouncement and initial 2017 outlook. The analyst has reduced conviction in Honeywell's execution after 3 quarters of EBIT misses and said Honeywell has become a "show me" story and lowered his price target to $122 from $131 on shares. Ritchie continues to rate Honeywell a Buy saying shares are cheap and fundamentals are above average but consistency in execution/communication needs to return to prior levels to help narrow the valuation gap.

10/10/16

OPCO

10/10/16NO CHANGETarget $122OPCOOutperform

Honeywell price target lowered to $122 from $128 at Oppenheimer

Oppenheimer analyst Christopher Glynn lowered his Q3 EPS expectations for Honeywell after the company cut its earnings and revenue outlook and trimmed his price target to $122 from $128. While he expects shares to be placed in the "penalty box" for some months, he maintains an Outperform rating on the stock, assuming the multiple on the stock can return to the level of Oct. 6 as investor sentiment normalizes.

10/10/16

10/10/16DOWNGRADE

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Honeywell (HON) downgraded to Buy from Conviction Buy at Goldman with analyst Christopher Glynn lowering his Q3 Earnings Per Share expectations for Honeywell after the company cut its earnings and revenue outlook and trimmed his price target to $122 from $128. 2. United Technologies (UTX) downgraded to Neutral from Buy at Citi with analyst Jason Gursky saying he sees three issues limiting share upside over the next twelve-plus months. 3. PNC Financial (PNC) was downgraded to Neutral from Buy at Nomura while the firm downgraded Fifth Third (FITB) to Reduce from Neutral. 4. Myriad Genetics (MYGN) downgraded to Sell from Neutral at Ladenburg with analyst Kevin DeGeeter citing a "significant and unexpected deterioration" in outlook for the company's companion diagnostic franchise. 5. HSN, Inc. (HSNI) downgraded to Hold from Buy at Craig-Hallum with analyst Alex Fuhrman saying his channel checks indicate continued weakness in the third quarter, with particular weakness in jewelry and consumer electronics. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

UP AFTER EARNINGS: Cintas (CTAS), up 2.9%... Micron (MU), up 2.8%. ALSO HIGHER: Editas Medicine (EDIT), up 3.1% after it received the EMA's orphan medicinal product designation for EDIT-101... Twitter (TWTR), up 1.8% after it said it will start testing longer, 280-character tweets with a small group. DOWN AFTER EARNINGS: Nike (NKE), down 3.2%. ALSO LOWER: Kornit Digital (KRNT), down 12.2% after it cut its third quarter revenue guidance... Westlake Chemical Partners (WLKP), down 8.3% after it filed to sell 4.5M units for limited partners... Intra-Cellular (ITCI), down 7.2% after it filed to sell $150M in common stock... Ascendis Pharma (ASND), down 4.3% after it announced an offering of $125M of ADSs.